News | Digital Radiography (DR) | January 25, 2021

FDA Clears Siemens Healthineers MULTIX Impact C Ceiling-Mounted DR System

myExam Companion user interface on both systems helps technologists of every experience level achieve consistently high image quality

myExam Companion user interface on both systems helps technologists of every experience level achieve consistently high image quality

January 25, 2021 — Siemens Healthineers has announced the Food and Drug Administration (FDA) clearance of the MULTIX Impact C ceiling-mounted digital radiography (DR) system as well as the MULTIX Impact VA20, a new version of the established floor-mounted parent DR system. Economically priced, both systems expand access to high-quality imaging and enhance the patient experience.

The MULTIX Impact C and the MULTIX Impact VA20 possess an intuitive operating system, versatile wireless detectors, motorized tube heads, and a free-floating, flat tabletop for easier patient access. With the X-ray tube’s touch user interface, the radiologic technologist can remain by the patient’s side for longer periods. And when in the control room, the technologist can continuously monitor the patient via the myExam 2-D camera.

The myExam Companion user interface on both systems provides proactive guidance to help technologists of any skill level navigate a radiography procedure. Combining available patient data with other user or machine-observable, patient-specific information, myExam Companion can identify optimal acquisition and reconstruction parameters for each patient and procedure.

With myExam Companion’s camera-based Smart Virtual Ortho feature, the technologist can set the field of view and adjust exposure parameters on the touchscreen using a live camera image of the patient, so long-leg and full-spine examinations can be set up and performed more easily. The Auto Full-Spine and Auto Long-Leg Collimation features use automated, artificial intelligence-based body part detection and collimation to accelerate spine and leg examination workflows by analyzing the patient’s contour and adjusting the collimator blades in under half a second.

“With this FDA clearance, Siemens Healthineers pushes the boundaries of what is possible in radiography,” said Niral Patel, Vice-President of X-ray Products at Siemens Healthineers North America. “We can now deliver both floor-mounted and ceiling-mounted options with automation, artificial intelligence, and safety features that expand our customers’ capabilities in digital radiography.”

For more information: www.siemens-healthineers.com

Related Content

News | Artificial Intelligence | May 11, 2021
May 11, 2021 — Whiterabbit, an AI technology company focused on early...
National Imaging Solutions, a recognized leader in medical imaging and radiology solutions, announced it has acquired DynaRad — the oldest manufacturer of portable X-ray systems in the US. This new investment will allow National Imaging Solutions to support its customers by supplying them with DynaRad portable X-ray machines, including a mobile field X-ray device using nanotube technology.
News | Radiology Business | May 11, 2021
May 11, 2021 — ...
3D aMRI not only provides a stunning look inside the "beating brain", but it can also measure this physiological motion in all directions. Here, the amplitude of brain motion is overlayed for each brain slice and orientation in 3D. Image credit: 3D aMRI method outlined in Abderezaei et al. Brain Multiphysics (2021); Terem et al. Magnetic Resonance in Medicine (2021).

3D aMRI not only provides a stunning look inside the "beating brain", but it can also measure this physiological motion in all directions. Here, the amplitude of brain motion is overlayed for each brain slice and orientation in 3D. Image credit: 3D aMRI method outlined in Abderezaei et al. Brain Multiphysics (2021); Terem et al. Magnetic Resonance in Medicine (2021).

News | Magnetic Resonance Imaging (MRI) | May 06, 2021
May 6, 2021 — Magnetic Resonance Imaging
Research finds that a commonly used risk-prediction model for lung cancer does not accurately identify high-risk Black patients who could benefit from early screening

Getty Images

News | Lung Imaging | May 05, 2021
May 5, 2021 — Lung cancer is the third most common cance
After radiosurgery concurrent with nivolumab in 59-year-old patient with melanoma BM (patient 1; Supplemental Tables 3 and 5), F-18 FET PET at follow-up 12 weeks after treatment initiation (bottom row) shows significant decrease of metabolic activity (TBRmean, ?28%) compared with baseline (top row), although MRI changes were consistent with progression according to iRANO criteria. Reduction of metabolic activity was associated with stable clinical course over 10 mo. CE = contrast-enhanced. Image created by

After radiosurgery concurrent with nivolumab in 59-year-old patient with melanoma BM (patient 1; Supplemental Tables 3 and 5), F-18 FET PET at follow-up 12 weeks after treatment initiation (bottom row) shows significant decrease of metabolic activity (TBRmean, ?28%) compared with baseline (top row), although MRI changes were consistent with progression according to iRANO criteria. Reduction of metabolic activity was associated with stable clinical course over 10 mo. CE = contrast-enhanced. Image created by N. Galldiks et al., Research Center Juelich, Juelich, Germany.

News | PET Imaging | May 05, 2021
May 5, 2021 — For patients with brain metastases, amino acid ...